Puglisi F - Search Results

1

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker.

Pelizzari G, Basile D, Zago S, Lisanti C, Bartoletti M, Bortot L, Vitale MG, Fanotto V, Barban S, Cinausero M, Bonotto M, Gerratana L, Mansutti M, Curcio F, Fasola G, Minisini AM, Puglisi F. Pelizzari G, et al. Among authors: puglisi f. Cancers (Basel). 2019 Aug 24;11(9):1243. doi: 10.3390/cancers11091243. Cancers (Basel). 2019. PMID: 31450641 Free PMC article.

2

Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer.

Puglisi F, Minisini AM, Aprile G, Barbone F, Cataldi P, Artico D, Damante G, Beltrami CA, Di Loreto C. Puglisi F, et al. Oncology. 2002;63(1):76-83. doi: 10.1159/000065724. Oncology. 2002. PMID: 12187075

3

Role of mammography, ultrasound and large core biopsy in the diagnostic evaluation of papillary breast lesions.

Puglisi F, Zuiani C, Bazzocchi M, Valent F, Aprile G, Pertoldi B, Minisini AM, Cedolini C, Londero V, Piga A, Di Loreto C. Puglisi F, et al. Oncology. 2003;65(4):311-5. doi: 10.1159/000074643. Oncology. 2003. PMID: 14707450

4

What is the effect of systemic anticancer treatment on cognitive function?

Minisini A, Atalay G, Bottomley A, Puglisi F, Piccart M, Biganzoli L. Minisini A, et al. Among authors: puglisi f. Lancet Oncol. 2004 May;5(5):273-82. doi: 10.1016/S1470-2045(04)01465-2. Lancet Oncol. 2004. PMID: 15120664 Review.

5

Galectin-3 expression in non-small cell lung carcinoma.

Puglisi F, Minisini AM, Barbone F, Intersimone D, Aprile G, Puppin C, Damante G, Paron I, Tell G, Piga A, Di Loreto C. Puglisi F, et al. Cancer Lett. 2004 Aug 30;212(2):233-9. doi: 10.1016/j.canlet.2004.03.006. Cancer Lett. 2004. PMID: 15279903

6

Tumor shrinkage evaluation during and after preoperative doxorubicin and cyclophosphamide followed by docetaxel in patients with breast cancer.

Puglisi F, Mansutti M, Aprile G, Minisini AM, Di Loreto C, Bazzocchi M, Londero V, Cedolini C, Gentile G, Pizzolitto S, Piga A, Sobrero A. Puglisi F, et al. Anticancer Res. 2004 Jul-Aug;24(4):2487-93. Anticancer Res. 2004. PMID: 15330203 Free article. Clinical Trial.

7

Topoisomerase IIalpha and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer.

Minisini AM, Di Loreto C, Mansutti M, Artico D, Pizzolitto S, Piga A, Puglisi F. Minisini AM, et al. Among authors: puglisi f. Cancer Lett. 2005 Jun 16;224(1):133-9. doi: 10.1016/j.canlet.2004.11.007. Epub 2004 Dec 13. Cancer Lett. 2005. PMID: 15911109

8

Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006.

Puglisi F, Andreetta C, Fasola G. Puglisi F, et al. Expert Opin Pharmacother. 2006 Nov;7(16):2309-18. doi: 10.1517/14656566.7.16.2309. Expert Opin Pharmacother. 2006. PMID: 17059386

9

Markers of the uPA system and common prognostic factors in breast cancer.

Minisini AM, Fabbro D, Di Loreto C, Pestrin M, Russo S, Cardellino GG, Andreetta C, Damante G, Puglisi F. Minisini AM, et al. Among authors: puglisi f. Am J Clin Pathol. 2007 Jul;128(1):112-7. doi: 10.1309/M0GXVXA89BVLJ5C9. Am J Clin Pathol. 2007. PMID: 17580278

10

Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells.

Puglisi F, Andreetta C, Valent F, Minisini AM, Rijavec E, Russo S, Mansutti M, Cardellino G, Pizzolitto S, Di Loreto C. Puglisi F, et al. Anticancer Drugs. 2007 Sep;18(8):883-8. doi: 10.1097/CAD.0b013e32816ebede. Anticancer Drugs. 2007. PMID: 17667593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters